Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy

被引:106
作者
Ma, Shoubao [1 ,2 ]
Caligiuri, Michael A. [1 ,2 ,3 ]
Yu, Jianhua [1 ,2 ,3 ,4 ]
机构
[1] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Los Angeles, CA 91010 USA
[2] City Hope Natl Med Ctr, Hematol Malignancies & Stem Cell Transplantat Inst, Los Angeles, CA 91010 USA
[3] City Hope Natl Med Ctr, Comprehens Canc Ctr, Los Angeles, CA 91010 USA
[4] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immuno Oncol, Los Angeles, CA 91010 USA
基金
美国国家卫生研究院;
关键词
NATURAL-KILLER-CELLS; RECOMBINANT HUMAN INTERLEUKIN-15; CD8; T-CELLS; RECEPTOR-ALPHA; CBL-B; SOLUBLE IL-15R-ALPHA; NEGATIVE REGULATOR; TUMOR PROGRESSION; DENDRITIC CELLS; CLINICAL-TRIAL;
D O I
10.1016/j.it.2022.08.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer (NK) cells, a crucial component of the innate immune system, have long been of clinical interest for their antitumor properties. Almost every aspect of NK cell immunity is regulated by interleukin-15 (IL-15), a cytokine in the common gamma-chain family. Several current clinical trials are using IL-15 or its ana-logs to treat various cancers. Moreover, NK cells are being genetically modified to produce membrane-bound or secretory IL-15. Here, we discuss the key role of IL-15 signaling in NK cell immunity and provide an up-to-date overview of IL-15 in NK cell therapy.
引用
收藏
页码:833 / 847
页数:15
相关论文
共 133 条
[1]   Increased Antitumor Effects Using IL-2 with Anti-TGF-β Reveals Competition between Mouse NK and CD8 T Cells [J].
Alvarez, Maite ;
Bouchlaka, Myriam N. ;
Sckisel, Gail D. ;
Sungur, Can M. ;
Chen, Mingyi ;
Murphy, William J. .
JOURNAL OF IMMUNOLOGY, 2014, 193 (04) :1709-1716
[2]  
ANDERSON DM, 1995, J BIOL CHEM, V270, P29862
[3]   The soluble α chain of interleukin-15 receptor:: A proinflammatory molecule associated with tumor progression in head and neck cancer [J].
Badoual, Cecile ;
Bouchaud, Gregory ;
Agueznay, Nour El Houda ;
Mortier, Erwan ;
Hans, Stephane ;
Gey, Alain ;
Fernani, Fahima ;
Peyrard, Severine ;
Laurent-Puig, Pierre ;
Bruneval, Patrick ;
Sastre, Xavier ;
Plet, Ariane ;
Garrigue-Antar, Laure ;
Quintin-Colonna, Francoise ;
Fridman, Wolf H. ;
Brasnu, Daniel ;
Jacques, Yannick ;
Tartour, Eric .
CANCER RESEARCH, 2008, 68 (10) :3907-3914
[4]   Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway [J].
Baldassarre, G ;
Fedele, M ;
Battista, S ;
Vecchione, A ;
Klein-Szanto, AJP ;
Santoro, M ;
Waldmann, TA ;
Azimi, N ;
Croce, CM ;
Fusco, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (14) :7970-7975
[5]   A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer Immunotherapy [J].
Becker-Hapak, Michelle K. ;
Shrestha, Niraj ;
McClain, Ethan ;
Dee, Michael J. ;
Chaturvedi, Pallavi ;
Leclerc, Gilles M. ;
Marsala, Lynne I. ;
Foster, Mark ;
Schappe, Timothy ;
Tran, Jennifer ;
Desai, Sweta ;
Neal, Carly C. ;
Pence, Patrick ;
Wong, Pamela ;
Wagner, Julia A. ;
Russler-Germain, David A. ;
Zhu, Xiaoyun ;
Spanoudis, Catherine M. ;
Gallo, Victor L. ;
Echeverri, Christian A. ;
Ramirez, Laritza L. ;
You, Lijing ;
Egan, Jack O. ;
Rhode, Peter R. ;
Jiao, Jin-an ;
Muniz, Gabriela J. ;
Jeng, Emily K. ;
Prendes, Caitlin A. ;
Sullivan, Ryan P. ;
Berrien-Elliott, Melissa M. ;
Wong, Hing C. ;
Fehniger, Todd A. .
CANCER IMMUNOLOGY RESEARCH, 2021, 9 (09) :1071-1087
[6]   Interleukin-2, interleukin-15, and their roles in human natural killer cells [J].
Becknell, B ;
Caligiuri, MA .
ADVANCES IN IMMUNOLOGY, VOL 86, 2005, 86 :209-239
[7]   Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum [J].
Bergamaschi, Cristina ;
Bear, Jenifer ;
Rosati, Margherita ;
Beach, Rachel Kelly ;
Alicea, Candido ;
Sowder, Raymond ;
Chertova, Elena ;
Rosenberg, Steven A. ;
Felber, Barbara K. ;
Pavlakis, George N. .
BLOOD, 2012, 120 (01) :E1-E8
[8]   Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity [J].
Bernard, Pierre-Louis ;
Delconte, Rebecca ;
Pastor, Sonia ;
Laletin, Vladimir ;
Da Silva, Cathy Costa ;
Goubard, Armelle ;
Josselin, Emmanuelle ;
Castellano, Remy ;
Krug, Adrien ;
Vernerey, Julien ;
Devillier, Raynier ;
Olive, Daniel ;
Verhoeyen, Els ;
Vivier, Eric ;
Huntington, Nicholas D. ;
Nunes, Jacques ;
Guittard, Geoffrey .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (05)
[9]   Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia [J].
Berrien-Elliott, Melissa M. ;
Foltz, Jennifer A. ;
Russler-Germain, David A. ;
Neal, Carly C. ;
Tran, Jennifer ;
Gang, Margery ;
Wong, Pamela ;
Fisk, Bryan ;
Cubitt, Celia C. ;
Marin, Nancy D. ;
Zhou, Alice Y. ;
Jacobs, Miriam T. ;
Foster, Mark ;
Schappe, Timothy ;
McClain, Ethan ;
Kersting-Schadek, Samantha ;
Desai, Sweta ;
Pence, Patrick ;
Becker-Hapak, Michelle ;
Eisele, Jeremy ;
Mosior, Matthew ;
Marsala, Lynne ;
Griffith, Obi L. ;
Griffith, Malachi ;
Khan, Saad M. ;
Spencer, David H. ;
DiPersio, John F. ;
Romee, Rizwan ;
Uy, Geoffrey L. ;
Abboud, Camille N. ;
Ghobadi, Armin ;
Westervelt, Peter ;
Stockerl-Goldstein, Keith ;
Schroeder, Mark A. ;
Wan, Fei ;
Lie, Wen-Rong ;
Soon-Shiong, Patrick ;
Petti, Allegra A. ;
Cashen, Amanda F. ;
Fehniger, Todd A. .
SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (633)
[10]   Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy [J].
Berrien-Elliott, Melissa M. ;
Becker-Hapak, Michelle ;
Cashen, Amanda F. ;
Jacobs, Miriam ;
Wong, Pamela ;
Foster, Mark ;
McClain, Ethan ;
Desai, Sweta ;
Pence, Patrick ;
Cooley, Sarah ;
Brunstein, Claudio ;
Gao, Feng ;
Abboud, Camille N. ;
Uy, Geoffrey L. ;
Westervelt, Peter ;
Jacoby, Meagan A. ;
Pusic, Iskra ;
Stockerl-Goldstein, Keith E. ;
Schroeder, Mark A. ;
DiPersio, John F. ;
Soon-Shiong, Patrick ;
Miller, Jeffrey S. ;
Fehniger, Todd A. .
BLOOD, 2022, 139 (08) :1177-1183